Literature DB >> 28746067

Perturbing NR2B-PSD-95 interaction relieves neuropathic pain by inactivating CaMKII-CREB signaling.

Fangxia Xu1, Xin Zhao, Lin Liu, Jia Song, Yingjun Zhu, Shuaishuai Chu, Xueming Shao, Xiuxiu Li, Zhengliang Ma, Xiaoping Gu.   

Abstract

Neuropathic pain is characterized by central sensitization. The interaction between N-methyl-D-aspartate receptors (NMDARs) and postsynaptic density protein-95 (PSD-95) plays a major role in central sensitization. Here, we aimed to investigate the analgesic effect of disruption of the interaction between NMDAR and PSD-95. Chronic dorsal root ganglia compression model rats were used to mimic sciatica. Thermal hyperalgesia and mechanical allodynia were evaluated. The expression of spinal phospho-NR2B, PSD-95, calcium/calmodulin-dependent protein kinase II (CaMKII), and cAMP response element binding protein (CREB) was measured using western blotting. A mimetic peptide Myr-NR2B9c was injected intrathecally to disrupt the interaction between PSD-95 and NR2B and detected by coimmunoprecipitation. Chronic dorsal root ganglia compression surgery induced thermal hyperalgesia and mechanical allodynia, and upregulated pain-related proteins such as phospho-NR2B, PSD-95, CaMKII, and CREB expressions in the spinal cord. Myr-NR2B9c disrupted the interaction between NR2B-containing NMDARs and PSD-95 in the spinal cord. Intrathecal administration of Myr-NR2B9c attenuated neuropathic pain behaviors and downregulated the expressions of phospho-NR2B, PSD-95, CaMKII, and CREB in the spinal cord. The present study indicates that dissociation of NR2B-containing NMDARs from PSD-95 inactivates CaMKII and CREB signaling and relieves pain.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28746067     DOI: 10.1097/WNR.0000000000000849

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  Roles of Phosphorylation of N-Methyl-D-Aspartate Receptor in Chronic Pain.

Authors:  Liangyu Pan; Tiansheng Li; Rui Wang; Weiheng Deng; Huangsheng Pu; Meichun Deng
Journal:  Cell Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.046

2.  Translocation Associated Membrane Protein 1 Contributes to Chronic Constriction Injury-Induced Neuropathic Pain in the Dorsal Root Ganglion and Spinal Cord in Rats.

Authors:  Dekun Yin; Yonglin Chen; Rongxiang Lu; Bingbing Fan; Shunxing Zhu; Xingguo Xu; Zhongling Xu
Journal:  J Mol Neurosci       Date:  2018-10-18       Impact factor: 3.444

3.  Long Noncoding RNA H19 Induces Neuropathic Pain by Upregulating Cyclin-Dependent Kinase 5-Mediated Phosphorylation of cAMP Response Element Binding Protein.

Authors:  Kai Li; Yuan Jiao; Xuli Ren; Di You; Rangjuan Cao
Journal:  J Pain Res       Date:  2020-08-20       Impact factor: 3.133

4.  Complement Receptor 3 Pathway and NMDA Receptor 2B Subunit Involve Neuropathic Pain Associated with Spinal Cord Injury.

Authors:  Yong Li; Sheng-Chun Fang; Lan Zhou; Xue-Mei Mo; Hao-Dong Guo; Yan-Bo Deng; Hong-Hao Yu; Wei-Yi Gong
Journal:  J Pain Res       Date:  2022-06-25       Impact factor: 2.832

5.  PSD-95 in the anterior cingulate cortex contributes to neuropathic pain by interdependent activation with NR2B.

Authors:  Ang Li; Chang-Jun Huang; Kai-Peng Gu; Yan Huang; Ya-Qin Huang; Hui Zhang; Jia-Piao Lin; Yu-Fan Liu; Yan Yang; Yong-Xing Yao
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

6.  N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.

Authors:  Ling-Er Huang; Shao-Hui Guo; Lalita Thitiseranee; Yan Yang; Yan-Feng Zhou; Yong-Xing Yao
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

7.  Dexmedetomidine Attenuates Neuropathic Pain by Inhibiting P2X7R Expression and ERK Phosphorylation in Rats.

Authors:  Jia-Piao Lin; Chao-Qin Chen; Ling-Er Huang; Na-Na Li; Yan Yang; Sheng-Mei Zhu; Yong-Xing Yao
Journal:  Exp Neurobiol       Date:  2018-08-30       Impact factor: 3.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.